Receive Our Newsletter

CSL Behring Celebrates World Hemophilia Day

industry_news_banner

Global Drug Manufacturer CSL Behring announced last week it’s recognition of World Hemophilia Day by sharing news of a donation of more than 4 million international units (IUs) of its medicines to treat hemophilia A and/or von Willebrand Disease to the WFH Global Alliance for Progress (GAP) Program.

To read the full release from CSL Behring, click here.

Comments (No comments)

Assisting and Advocating for the Bleeding Disorders Community